Peter de Vries

Peter de Vries has over 13 years of work experience in the field of biotechnology. Peter is currently the Director of Scientific Project Management, Preclinical at Icosavax, Inc. and the Founder & President of Broadview Biotech Consulting, LLC. Prior to this, they were the Senior Director Biology at ApoGen Biotechnologies, Inc. (2018), Strategic Director at Fred Hutch (2018), Director Cancer Biology & Pharmacology at Cascadian Therapeutics, Inc. (2016), Senior Commercialization Officer, Vaccine Development Global Program at PATH (2014), Principal and Founder at Broadview Biotech Consulting (2011), Associate Director Biology at Acylin Therapeutics (2013), Associate Director Translational Sciences at Ikaria (2008), and Study Director at SNBL USA (2007).

Peter de Vries obtained a Doctor of Philosophy (Ph.D.) in Hematology/Stem Cell Biology from Erasmus University Rotterdam, a Master's Degree in Immunology from Leiden University, a Bachelor's Degree in Biochemistry from Leiden University, and an MBA from the University of Washington Bothell.